Optomed PLC
The answer first
Does Optomed beat the market?
No, Optomed has not beaten the market over the last year.
The ranking · Quality, value and trend combined
Better than 48% of Nordic stocks
- Quality70
- Value31
- Trend52
No. 62 of 195 in healthcare
Max for seven days
Follow Optomed with AuroraAurora lets you know at the next report. No card.
Both with dividends. Figures as of 18 November 2026. General analysis, not personal advice.
Follow your thesis
Ask Aurora about Optomed
Your first answer is free, no account needed.
Do you own Optomed, or are you thinking about it?
See it next to the rest of your portfolio, or build your first one with Optomed and a few more. Free, no card.
Super Stock+45.9%In short
- Optomed has fallen 56.7% over the past year, including dividends.
- Overall, Optomed ranks better than 48% of Nordic stocks on quality, value and trend.
- The largest fall over the past three years was 85.6%. The price is 90.7% below its peak now.
What do analysts think of Optomed?
Quality, value and trend
Quality is about the company, value about the price you pay, and trend about the share price. Each pillar shows the numbers it is built on.
Quality, value and trend together. Better than 48% of Nordic stocks.
No. 62 of 195 in healthcare
High A solid company: it earns well on its money and has healthy finances.
No. 84 of 196 in healthcareTypical in healthcare: 64Typical in the Nordics: 50
- Debt to equityBorrowings divided by equity0.15
- Asset turnoverSales divided by everything the company owns0.57
- Return on equityProfit divided by equity−15.4%
- Cash conversionOperating cash flow divided by profit–
The ranking is built on equity ratio, ROA and how steadily profit grows.
Low High price: buyers pay a lot today, often because they expect growth.
No. 75 of 197 in healthcareTypical in healthcare: 21Typical in the Nordics: 50
- P/BPrice divided by equity1.6
- P/SPrice divided by sales2.1
- P/EPrice divided by earningsnegative earnings
- P/CFPrice divided by operating cash flownegative earnings
The ranking is built on P/E, P/B and P/S.
Medium The share price has moved about like most stocks over the last year.
No. 68 of 198 in healthcareTypical in healthcare: 34Typical in the Nordics: 50
- 3 months+5.7%
- 6 months+15.2%
- 9 months−39.7%
- 12 months−56.7%
The ranking is built on 3, 6 and 12–1 months.
Return and risk
Return with dividends reinvested.
The funds that own Optomed
One fund we follow owns Optomed. The share is how much of the fund the stock makes up.
- Sweden1
From the funds' latest known holdings.
About Optomed
Optomed PLC is a company in healthcare, listed on Nasdaq Helsinki. The share trades in EUR. It has around 100 employees.
Optomed Oyj, together with its subsidiaries, manufactures and sells handheld fundus cameras in Finland, rest of Europe, and internationally. The company operates in two segments, Devices and Software. It develops, manufactures, and sells fundus cameras for ophthalmologists, pediatricians, endocrinologists, neurologists, and primary health care professionals; and provides professional IT consulting services for government institutions. The company also provides camera products under the Optomed Smartscope Pro, Optomed Aurora, Optomed Aurora AEYE, Optomed Polaris, and Optomed Lumo brand names, as well as OEM cameras under the Volk Optical, Carl Zeiss Meditec, and Topcon brands.


See the full analysis of Optomed.
The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.
Free forever · No card